Annual Drug Patent Expirations for CLINDESSE Clindesse is a drug marketed by Padagis Us and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Padagis Us drug CLINDESSE appeared first on…
New patent expiration for Padagis Us drug CLINDESSE Read Post »
Annual Drug Patent Expirations for FOTIVDA Fotivda is a drug marketed by Aveo Pharms and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Aveo Pharms drug FOTIVDA appeared first on D…
New patent expiration for Aveo Pharms drug FOTIVDA Read Post »
CLINDESSE (clindamycin phosphate) Padagis us Patent: 6,899,890 Expiration: Apr 27, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dr…
Drug Patent Expirations for the Week of April 23, 2023 Read Post »
Annual Drug Patent Expirations for DUTREBIS Dutrebis is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are five patents protecting this drug. This drug…
The post New patent expiration for Merck Sharp drug DUTREBIS appeared first…
New patent expiration for Merck Sharp drug DUTREBIS Read Post »
Annual Drug Patent Expirations for ISENTRESS+HD Isentress Hd is a drug marketed by Msd Sub Merck and is included in one NDA. It is available from eight suppliers. There are…
The post New patent expiration for Msd Sub drug ISENTRESS HD appeared first on…
New patent expiration for Msd Sub drug ISENTRESS HD Read Post »
Annual Drug Patent Expirations for DUTREBIS Dutrebis is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are five patents protecting this drug. This drug…
The post New patent expiration for Merck Sharp drug DUTREBIS appeared first…
New patent expiration for Merck Sharp drug DUTREBIS Read Post »
Annual Drug Patent Expirations for ISENTRESS Isentress is a drug marketed by Msd Sub Merck and is included in three NDAs. It is available from eight suppliers. There are six…
The post New patent expiration for Msd Sub drug ISENTRESS appeared first on D…
New patent expiration for Msd Sub drug ISENTRESS Read Post »
Annual Drug Patent Expirations for ISENTRESS Isentress is a drug marketed by Msd Sub Merck and is included in three NDAs. It is available from eight suppliers. There are six…
The post New patent expiration for Msd Sub drug ISENTRESS appeared first on D…
New patent expiration for Msd Sub drug ISENTRESS Read Post »
Annual Drug Patent Expirations for TESTIM Testim is a drug marketed by Auxilium Pharms Llc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Auxilium Pharms drug TESTIM appeared first on Dr…
New patent expiration for Auxilium Pharms drug TESTIM Read Post »
TESTIM (testosterone) Auxilium pharms llc Patent: 7,608,610 Expiration: Apr 21, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug …
Drug Patent Expirations for the Week of April 16, 2023 Read Post »